MTOR and angiomyolipoma: Immunohistochemistry studies showed low expression of tuberin (TSC2) in angiomyolipoma, which contains activated mTOR signals, compared to healthy kidneys, authenticating the suppression role of TSC2 on mTOR activity [75].